An interventional study of Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0) in Post-Traumatic Stress Disorder (PTSD), Depression and Substance Use Disorder, sponsored by Medical University of South Carolina. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment
This study evaluates the implementation and clinical effectiveness of the Trauma Resilience and Recovery Program (TRRP 2.0), a technology-enhanced behavioral health intervention designed for trauma center patients. TRRP 2.0 integrates screening, monitoring, and referral services for posttraumatic stress disorder (PTSD), depression, and substance use disorder (SUD).
The study uses a two-phase design across two trauma centers: a usual care phase followed by implementation of TRRP 2.0. A total of 300 adult trauma patients will be recruited and followed for 3 months to assess behavioral health service utilization and clinical outcomes.
Each year, over 600,000 of the 3 million U.S. patients hospitalized for traumatic injuries develop PTSD or depression within a year post-injury. Despite the 2022 American College of Surgeons (ACS) mandate for routine mental health screening and treatment, many trauma centers struggle to implement effective programs due to a lack of clear implementation roadmaps and operational barriers. The Trauma Resilience and Recovery Program (TRRP), developed by the Medical University of South Carolina (MUSC), addresses these gaps with a comprehensive, evidence-based intervention designed to meet the behavioral health needs of trauma patients. TRRP includes a web-based, HIPAA-compliant provider navigator platform that is cost-efficient and unique in its ability to facilitate improved screening accuracy at the bedside and efficient screening and referral post-discharge. The TRRP model and navigator platform have been used and sustained at MUSC since 2015 and have been adopted by over a dozen trauma centers. However, while adopters have noted several benefits of the platform, they emphasize two top-priority needs to facilitate adherence to ACS guidelines, ensure workload efficiencies that reduce provider burden, and minimize patient data capture errors: 1) integration of resources to facilitate screening and intervention for substance use disorders (SUD), and 2) the ability to read from and write to the electronic medical record (EMR). In this Phase I STTR, FRD Accel will partner with the MUSC team to enhance and de-risk an upgraded navigation platform-TRRP 2.0-to improve its scalability nationally in preparation for commercial launch. Our upgraded TRRP 2.0 platform will add features for integrated screening, intervention, and referral for SUD in addition to PTSD and depression. This will reduce provider burden and ensure compliance with ACS guidelines, promoting comprehensive care and optimizing patient outcomes. The specific aims for Phase I STTR are to 1) improve the TRRP platform by integrating new resources to facilitate the screening and referral of trauma patients with SUD and enabling communication with the Epic EMR (months 1-8), and 2) evaluate the clinical effectiveness of the TRRP 2.0 platform on post-discharge follow-up, behavioral health service utilization, and mental health outcomes among a sample of 300 adult trauma injury survivors (months 3-22). Successful completion of Phase I will validate TRRP 2.0's capacity to meet trauma centers' needs for integrated behavioral health services. The anticipated results will demonstrate the platform's ability to enhance patient care, streamline provider workflows, and ensure adherence to ACS standards. This will justify the transition to Phase II, where we will focus on broader dissemination, further development, and commercialization of the platform to maximize its impact across trauma centers nationwide.
Exclusion Criteria:
ACS adherent usual care for SBIRT and Behavioral Health Screening and Referral
Behavioral: Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0)
Service delivery via TRRP 2.0
Behavioral: Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0)
TRRP 2.0 is an enhanced, technology-supported behavioral health care model for patients hospitalized after traumatic injury. The intervention includes bedside behavioral health and substance use screening, education about emotional recovery, enrollment in post-discharge follow-up services, automated symptom monitoring and education via text messaging, follow-up behavioral health screening, and referral to treatment when indicated. The TRRP 2.0 provider navigation platform supports delivery and tracking of these services and includes integrated substance use screening/intervention resources and Epic electronic medical record read/write functionality.
Posttraumatic Stress Symptom Severity as Measured by the PCL-8
The PTSD Checklist for DSM-5 (Weathers et al., 2013) is a self-report measure that assesses the extent to which participants are bothered by the DSM-5 PTSD symptoms. Each symptom is rated on a scale of 0 (not at all) to 4 (extremely). Total scores are obtained by summing the scores of all items. The 8-item adaptation includes assessment of intrusive thoughts, avoidance of external reminders, negative expectations of self/ world, easily startled, emotional cue reactivity, avoidance of thoughts/emotions, loss of interest, and difficulty concentrating.
Time frame: 3-month post-baseline
Number of Participants Screening Positive for Posttraumatic Stress Risk on the Injured Trauma Survivor Screen (ITSS)
Posttraumatic stress risk is assessed using the ITSS. Five items are scored yes=1 and no=0 and summed. Participants with a score of 2 or greater are classified as screening positive for risk of posttraumatic stress.
Time frame: Baseline
Change in Psychological Distress as Measured by the Kessler-6 (K6)
The Kessler 6 (K6; Kessler et al., 2003) is a screening scale for nonspecific distress to discriminate cases of several mental illness. Items are rated on a 5-point Likert scale (1-5). Total scores range from 6-30 and are calculated as the sum of all item ratings, with a total score ³ 13 indicating severe mental illness. This measure has been shown to have strong psychometric properties.
Time frame: Baseline, 3-month postbaseline
Depressive Symptom Severity as Measured by the PHQ-8
The Patient Health Questionniare-9 (PHQ-9; Kroenke, Spitzer, \& Williams, 2001) assesses the presence and frequency of 9 core depressive symptoms. Items are rated on a 4-point Likert scale (0-3). Total scores range from 0-27 and are calculated as the sum of all item ratings, with a total score of ≥ 10 indicating clinical significance.
Time frame: 3 months postbaseline
Frequency of Alcohol Use as Measured by the NIDA Quick Screen
The NIDA Quick Screen (NIDA, 2010) is a validated instrument designed to assist providers in screening adults for substance use. The screen simply inquires whether a participant has used drugs (mood-altering, illegal, or prescription for nonmedical reasons), alcohol, or tobacco products within the past year and how often these substances have been used.
Time frame: 3 months postbaseline
General Life Satisfaction as Measured by PROMIS General Life Satisfaction
The 10-item PROMIS General Life Satisfaction questionnaire (Salsman et al., 2014) measures one's perception of life experiences and whether one likes his/her life or not.
Time frame: 3 months postbaseline
Frequency of Tobacco Use as Measured by the NIDA Quick Screen
Tobacco use is assessed using the NIDA Quick Screen. Participants report the frequency of tobacco product use during the past year using the response categories never, once or twice, monthly, weekly, or daily/almost daily.
Time frame: 3 months postbaseline
Frequency of Prescription Drug Use for Nonmedical Reasons as Measured by the NIDA Quick Screen
Nonmedical prescription drug use is assessed using the NIDA Quick Screen. Participants report frequency of prescription drug use for nonmedical reasons during the past year using the response categories never, once or twice, monthly, weekly, or daily/almost daily.
Time frame: 3 months postbaseline
Frequency of Illegal Drug Use as Measured by the NIDA Quick Screen
Illegal drug use is assessed using the NIDA Quick Screen. Participants report frequency of illegal drug use during the past year using the response categories never, once or twice, monthly, weekly, or daily/almost daily.
Time frame: 3 months postbaseline
Number of Participants Screening Positive for Depression Risk on the Injured Trauma Survivor Screen (ITSS)
Depression risk is assessed using the ITSS. Five items are scored yes=1 and no=0 and summed. Participants with a score of 2 or greater are classified as screening positive for risk of depression.
Time frame: Baseline
Hospital Length of Stay
Length of stay for the index traumatic injury hospitalization will be obtained from the electronic medical record and reported in days.
Time frame: Baseline
Electronic Medical Record Data
Data will be collected at baseline via the electronic medical record including patients' length of stay; injury severity scores; number of emergency department visits; and opioid, anti-anxiety and anti-depression medications prescribed.
Time frame: Baseline
National Health Interview Survey Adult Access to Health Care and Utilization Module
This protocol includes 10 interviewer-administered questions from the National Health Interview Survey (NHIS) Adult Access to Health Care \& Utilization Module (CDC, 2019) designed to assess when medical care was last sought, usual place of care, frequency of getting medical treatment.
Time frame: 3 months postbaseline
Injury Severity Score (ISS)
Injury Severity Score associated with the index traumatic injury will be obtained from the electronic medical record. ISS ranges from 1 to 75, with higher scores indicating greater injury severity.
Time frame: Baseline
Number of Emergency Department Visits
Number of emergency department visits occurring during the specified period will be obtained from the electronic medical record.
Time frame: 3 months postbaseline
Number of Participants Prescribed Opioid Medication
Number of participants with an opioid medication prescription documented in the electronic medical record during the specified period.
Time frame: 3 months postbaseline
Number of Participants Prescribed Anti-Anxiety Medication
Number of participants with an anti-anxiety medication prescription documented in the electronic medical record during the specified period.
Time frame: 3 months postbaseline
Number of Participants Prescribed Antidepressant Medication
Number of participants with an antidepressant medication prescription documented in the electronic medical record during the specified period.
Time frame: 3 months postbaseline
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic→
Medical University of South Carolina